Poly (ADP-ribose) polymerase (PARP) and PARP inhibitors: mechanisms of action and role in cardiovascular disorders

RJ Henning, M Bourgeois, RD Harbison - Cardiovascular toxicology, 2018 - Springer
Poly (ADP-ribosyl) ation is an immediate cellular repair response to DNA damage and is
catalyzed primarily by poly (ADP-ribose) polymerase-1 (PARP1), which is the most …

Role of poly (ADP‐ribose) polymerase 1 (PARP‐1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors

P Pacher, C Szabó - Cardiovascular drug reviews, 2007 - Wiley Online Library
Accumulating evidence suggests that the reactive oxygen and nitrogen species are
generated in cardiomyocytes and endothelial cells during myocardial ischemia/reperfusion …

The piRNA CHAPIR regulates cardiac hypertrophy by controlling METTL3-dependent N6-methyladenosine methylation of Parp10 mRNA

XQ Gao, YH Zhang, F Liu, M Ponnusamy, XM Zhao… - Nature cell …, 2020 - nature.com
PIWI-interacting RNAs (piRNAs) are abundantly expressed during cardiac hypertrophy.
However, their functions and molecular mechanisms remain unknown. Here, we identified a …

Discovery of new therapeutic redox targets for cardioprotection against ischemia/reperfusion injury and heart failure

A Daiber, I Andreadou, M Oelze, SM Davidson… - Free Radical Biology …, 2021 - Elsevier
Global epidemiological studies reported a shift from maternal/infectious communicable
diseases to chronic non-communicable diseases and a major part is attributable to …

[HTML][HTML] Magnesium and liver disease

M Liu, H Yang, Y Mao - Annals of translational medicine, 2019 - ncbi.nlm.nih.gov
Magnesium is a vital cation that takes part in many cellular processes. Magnesium balance
can be disturbed in multiple conditions, and differences in magnesium concentration can be …

Cardioprotective effect of resveratrol in a postinfarction heart failure model

A Riba, L Deres, B Sumegi, K Toth… - Oxidative medicine …, 2017 - Wiley Online Library
Despite great advances in therapies observed during the last decades, heart failure (HF)
remained a major health problem in western countries. In order to further improve symptoms …

Chromatin remodeling in cardiovascular development and physiology

P Han, CT Hang, J Yang, CP Chang - Circulation research, 2011 - Am Heart Assoc
Chromatin regulation provides an important means for controlling cardiac gene expression
under different physiological and pathological conditions. Processes that direct the …

Role of Akt activation in PARP inhibitor resistance in cancer

F Gallyas Jr, B Sumegi, C Szabo - Cancers, 2020 - mdpi.com
Poly (ADP-ribose) polymerase (PARP) inhibitors have recently been introduced in the
therapy of several types of cancers not responding to conventional treatments. However, de …

Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface

TA McKinsey, DA Kass - Nature Reviews Drug Discovery, 2007 - nature.com
Pathological stress from cardiovascular disease stimulates hypertrophy of heart cells, which
increases the risk of cardiac morbidity and mortality. Recent evidence has indicated that …

Docosahexaenoic acid (DHA) and hepatic gene transcription

DB Jump, D Botolin, Y Wang, J Xu, O Demeure… - Chemistry and physics …, 2008 - Elsevier
The type and quantity of dietary fat ingested contributes to the onset and progression of
chronic diseases, like diabetes and atherosclerosis. The liver plays a central role in whole …